- Home
- RAND vs YI Comparison
RAND vs YI Comparison
Compare RAND & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- YI
- Stock Information
- Founded
- RAND 1969
- YI 2010
- Country
- RAND United States
- YI China
- Employees
- RAND N/A
- YI N/A
- Industry
- RAND Finance: Consumer Services
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- RAND Finance
- YI Consumer Staples
- Exchange
- RAND Nasdaq
- YI Nasdaq
- Market Cap
- RAND 52.9M
- YI 56.5M
- IPO Year
- RAND N/A
- YI N/A
- Fundamental
- Price
- RAND $19.80
- YI $7.50
- Analyst Decision
- RAND
- YI
- Analyst Count
- RAND 0
- YI 0
- Target Price
- RAND N/A
- YI N/A
- AVG Volume (30 Days)
- RAND 9.1K
- YI 24.0K
- Earning Date
- RAND 05-12-2025
- YI 05-22-2025
- Dividend Yield
- RAND 24.79%
- YI N/A
- EPS Growth
- RAND 35.26
- YI N/A
- EPS
- RAND 3.42
- YI N/A
- Revenue
- RAND $8,559,285.00
- YI $1,973,017,082.00
- Revenue This Year
- RAND N/A
- YI N/A
- Revenue Next Year
- RAND N/A
- YI N/A
- P/E Ratio
- RAND $5.79
- YI N/A
- Revenue Growth
- RAND 16.64
- YI N/A
- 52 Week Low
- RAND $13.69
- YI $0.41
- 52 Week High
- RAND $31.89
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- RAND 50.99
- YI 46.64
- Support Level
- RAND $17.07
- YI $6.07
- Resistance Level
- RAND $20.00
- YI $7.74
- Average True Range (ATR)
- RAND 1.27
- YI 0.65
- MACD
- RAND 0.29
- YI -0.10
- Stochastic Oscillator
- RAND 70.53
- YI 50.53
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.